Genie Biotech EU

Booth 2455
Vilnius, Lithuania
Genie Biotech is a biotechnology company located in the UK, and Lithuania (Europe), that specializes in offering novel bioconjugation platform technologies. Formed in 2018 by research scientists from the Universities of Imperial College London and Oxford, Genie Biotech soon developed its first preclinical-stage site-specific conjugation chemistry (patent pending) offering a Proof-of-Concept/Out-Licensing model to clients looking to explore novel modalities that improve their therapeutic and vaccine pipeline candidates.